Valuation dashboard for BillionToOne, Inc. (BLLN) with P/E 170.78, P/B 9.15, EV/EBITDA 88.89 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection.
Analysis Summary
Trailing-twelve-month margins: gross margin 71.3%, operating margin 10.9%, net margin 8.4%.
At the current price of $105.90, BLLN trades at a P/E of 170.78 and an ROE of 7.87%. Market capitalisation stands at $4.9B.
Balance sheet quality for BLLN: current ratio of 11.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 170.78 |
| Price / Book | 9.15 |
| EV / EBITDA | 88.89 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $1,337.97 |
| vs Current Price | +1,163.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| BLLN | BillionToOne, Inc. | $4.9B | 170.78 | 9.15 | 7.9% |
| 0R0H.L | Thermo Fisher Scientific Inc. | $252.0B | |||
| TMO | Thermo Fisher Scientific Inc. | $242.1B | 35.22 | 4.61 | 13.4% |
| 0R2B.L | Danaher Corporation | $161.2B | |||
| DHR | Danaher Corporation | $150.5B | 38.02 | 2.87 | 6.9% |
| NTRA | Natera, Inc. | $58.5B | 32.28 | -12.2% | |
| 0HAV.L | Agilent Technologies, Inc. | $54.2B | 33.65 | 6.56 | 20.5% |
| A | Agilent Technologies, Inc. | $47.4B | 33.03 | 6.43 | 20.5% |
Price
| Price | $105.90 |
| Market Cap | $4.9B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 7.87% |
| Return on Invested Capital | 6.33% |
| Return on Assets | 4.59% |
| Gross Margin | 71.27% |
| Operating Margin | 10.90% |
| Net Margin | 8.43% |
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of BLLN: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks